1D-(1,3,6/2)-6-amino-4-benzyloxymethyl-1,2,3-tri-O-benzyltrihydroxycyclohex-4-ene

Names

[ CAS No. ]:
114779-32-7

[ Name ]:
1D-(1,3,6/2)-6-amino-4-benzyloxymethyl-1,2,3-tri-O-benzyltrihydroxycyclohex-4-ene

[Synonym ]:
.4,5,6,7-tetra-O-benzylvalienamine
.tetra-O-benzylvalienamine
(1R)-(1,2,4/3)-2,3,4-tribenzyloxy-5-benzyloxymethylcyclohex-5-enylamine
.tetrabenzylvalienamine

Chemical & Physical Properties

[ Molecular Formula ]:
C35H37NO4

[ Molecular Weight ]:
535.67300

[ Exact Mass ]:
535.27200

[ PSA ]:
62.94000

[ LogP ]:
6.92700

Synthetic Route

Precursor & DownStream

Precursor

  • (4R,5S,6R)-4,5,6-tris(benzyloxy)-3-((benzyloxy)methyl)-2-cyclohexen-1-one

DownStream

  • Validamycin
  • Valienamine

Related Compounds

  • 2-(1,3-benzothiazol-2-yl)-1-(4-chlorophenyl)-4a,5,6,7,8,8a-hexahydro-1H-chromeno[2,3-c]pyrrole-3,9-dione
  • 7-bromo-2-(5-methyl-1,2-oxazol-3-yl)-1-(3-propoxyphenyl)-4a,5,6,7,8,8a-hexahydro-1H-chromeno[2,3-c]pyrrole-3,9-dione
  • 2-(6-methyl-1,3-benzothiazol-2-yl)-1-(5-methylfuran-2-yl)-4a,5,6,7,8,8a-hexahydro-1H-chromeno[2,3-c]pyrrole-3,9-dione
  • 2-(6-ethoxy-1,3-benzothiazol-2-yl)-1-(3-hydroxyphenyl)-4a,5,6,7,8,8a-hexahydro-1H-chromeno[2,3-c]pyrrole-3,9-dione
  • 1-(3,4-dichlorophenyl)-6,7-dimethyl-2-(5-methyl-1,2-oxazol-3-yl)-4a,5,6,7,8,8a-hexahydro-1H-chromeno[2,3-c]pyrrole-3,9-dione
  • 7-ethyl-2-(5-methyl-1,2-oxazol-3-yl)-1-(3-phenylmethoxyphenyl)-4a,5,6,7,8,8a-hexahydro-1H-chromeno[2,3-c]pyrrole-3,9-dione
  • 2-(1,3-benzothiazol-2-yl)-1-(2,5-dimethoxyphenyl)-4a,5,6,7,8,8a-hexahydro-1H-chromeno[2,3-c]pyrrole-3,9-dione
  • 2-(6-fluoro-1,3-benzothiazol-2-yl)-1-(3-propoxyphenyl)-4a,5,6,7,8,8a-hexahydro-1H-chromeno[2,3-c]pyrrole-3,9-dione
  • 1-(5-methylfuran-2-yl)-2-(6-propan-2-yl-1,3-benzothiazol-2-yl)-4a,5,6,7,8,8a-hexahydro-1H-chromeno[2,3-c]pyrrole-3,9-dione
  • 2-(3-imidazol-1-ylpropyl)-1-phenyl-4a,5,6,7,8,8a-hexahydro-1H-chromeno[2,3-c]pyrrole-3,9-dione
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.